Pomelo Care Secures $92M Series C Funding Led by Stripes

Why It Matters

The capital infusion accelerates Pomelo’s expansion into year‑round women’s and pediatric health, positioning it to reshape cost structures and access in a fragmented market. Investors see scalable, outcomes‑driven digital health as a catalyst for industry‑wide change.

Key Takeaways

• Raised $92M Series C, valuing Pomelo at $1.7B
• Supports 7% of U.S. births with virtual care
• Model cuts preterm births, NICU stays, costs
• Expanding services beyond maternity to lifelong women/children care
• Backed by Stripes, Andreessen Horowitz, Atomico, others

Pulse Analysis

The $92 million Series C injection arrives at a pivotal moment for digital health, as venture capital increasingly targets platforms that combine data‑driven outcomes with scalable delivery. Leading investors such as Stripes and Andreessen Horowitz signal confidence that Pomelo’s technology stack and clinical protocols can generate sustainable returns while addressing systemic inefficiencies. This funding round not only boosts Pomelo’s balance sheet but also validates a broader market appetite for virtual care solutions that can be integrated with existing payer and employer benefit structures.

Pomelo’s core offering—virtual maternity care—has produced measurable reductions in preterm deliveries, NICU admissions, and overall treatment costs. By integrating medical, behavioral, and social determinants of health into a 24/7, multispecialty platform, the company delivers a continuity of care that traditional fragmented models struggle to match. These outcomes translate into lower claim expenses for insurers and employers, while improving health equity for underserved populations. The evidence‑based approach also generates robust data sets that can inform future clinical guidelines and policy decisions.

Looking ahead, Pomelo’s ambition to extend its model beyond pregnancy into pediatric, hormonal, and preventive health creates a sizable addressable market. As the U.S. healthcare system pivots toward value‑based care, providers and payers will seek partners that can deliver cost‑effective, high‑quality services across the care continuum. Pomelo’s expanded portfolio positions it to become a one‑stop digital health hub for women and children, potentially setting new standards for integrated, outcomes‑focused care and prompting competitive responses from both traditional health systems and emerging telehealth entrants.

Deal Summary

Pomelo Care announced a $92 million Series C round, valuing the company at $1.7 billion. The round was led by Stripes with participation from Andreessen Horowitz, PLUS Capital, Atomico, BoxGroup, and SV Angel. The funding will support expansion of its virtual maternity‑care model to broader women and children health services.